Efficacy and Safety of Omalizumab in Japanese and Korean Patients with Chronic Idopathic/Spontaneous Urticaria (CIU/CSU: Results from the Phase 3 POLARIS Study

Main Article Content

Michihiro Hide
Hae-Sim Park
Atsuyuki Igarashi
Young-Min Ye
Tae-Bum Kim
Akiko Yagami


omalizumab, efficacy, safety, clinical trial, urticaria


Abstract Not Available

Most read articles by the same author(s)